Clinical Trial Update: Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the anti-inflammatory effects of oral clarithromycin in community-acquired pneumonia and sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Sepsis

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: Hellenic Institute for the Study of Sepsis | Conditions: Community-acquired Pneumonia, Sepsis | Phase 3 | Status: COMPLETED